These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. TNFalpha antagonist therapy in patients with joint disease and chronic viral infection. Wendling D; Herbein G Joint Bone Spine; 2007 Oct; 74(5):407-9. PubMed ID: 17644391 [No Abstract] [Full Text] [Related]
4. [Viruses and oxidative stress]. Weismann H Dtsch Med Wochenschr; 1996 May; 121(21):A8. PubMed ID: 8646971 [No Abstract] [Full Text] [Related]
5. [Oxidative stress in HIV infections]. Jarstrand C; Akerlund B Lakartidningen; 1993 Aug; 90(32-33):2669-70. PubMed ID: 8103136 [No Abstract] [Full Text] [Related]
6. Oral viral infections and the therapeutic use of antiviral agents in dentistry. McCullough MJ; Savage NW Aust Dent J; 2005 Dec; 50(4 Suppl 2):S31-5. PubMed ID: 16416715 [TBL] [Abstract][Full Text] [Related]
7. Virus population dynamics, fitness variations and the control of viral disease: an update. Domingo E; Mas A; Yuste E; Pariente N; Sierra S; Gutiérrez-Riva M; Menéndez-Arias L Prog Drug Res; 2001; 57():77-115. PubMed ID: 11728003 [TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of viral infections in stem cell transplant recipients. Ljungman P Br J Haematol; 2002 Jul; 118(1):44-57. PubMed ID: 12100127 [No Abstract] [Full Text] [Related]
9. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells. Chen C; Johnston TD; Reddy KS; Merrick JC; Mastrangelo M; Ranjan D J Surg Res; 2001 Oct; 100(2):166-70. PubMed ID: 11592787 [TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species and nitric oxide in viral diseases. Peterhans E Biol Trace Elem Res; 1997 Jan; 56(1):107-16. PubMed ID: 9152514 [TBL] [Abstract][Full Text] [Related]
11. Iron withholding: a defense against viral infections. Weinberg ED Biometals; 1996 Oct; 9(4):393-9. PubMed ID: 8837461 [TBL] [Abstract][Full Text] [Related]
12. [Role of free radicals, oxidative stress and antioxidant systems in liver diseases]. Jakus V; Lopuchova M Bratisl Lek Listy; 1999; 100(10):548-59. PubMed ID: 10649852 [TBL] [Abstract][Full Text] [Related]
13. Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation. Peterhans E J Nutr; 1997 May; 127(5 Suppl):962S-965S. PubMed ID: 9164274 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Modulation of Virus-Induced Oxidative Stress via the Nrf2-Dependent Antioxidative Pathway. Lee C Oxid Med Cell Longev; 2018; 2018():6208067. PubMed ID: 30515256 [TBL] [Abstract][Full Text] [Related]
16. [Antioxidant therapy in chronic liver diseases]. Lengyel G; Tulassay Z Orv Hetil; 2006 Jun; 147(24):1113-8. PubMed ID: 16865855 [TBL] [Abstract][Full Text] [Related]
17. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress]. Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616 [TBL] [Abstract][Full Text] [Related]
18. Oxidative stress in viral hepatitis and AIDS. Stehbens WE Exp Mol Pathol; 2004 Oct; 77(2):121-32. PubMed ID: 15351235 [TBL] [Abstract][Full Text] [Related]
19. [Oxidative stress and HIV infection. A concept to be specified and a therapeutic approach to be studied]. Constans J; Conri C; Pellegrin JL; Sergeant C; Simonoff M; Peuchant E; Dubourg L; Thomas MJ; Pellegrin I; Brossard G Ann Med Interne (Paris); 1995; 146(7):514-9. PubMed ID: 8787295 [No Abstract] [Full Text] [Related]
20. [Antiviral humanized and human monoclonal antibodies]. Lashkevich VA Vopr Virusol; 2011; 56(5):4-8. PubMed ID: 22171470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]